Cgmp clinical supplies manufacturing, qualification and stability testing of tarp: 1-20AND 21-40 me tarp peptide and TWS-119 stability study
Ended Awarded Last action
- Contract number
- 75N91019F00133
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $341,913
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $341,913.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $27,737 | |
| Exercise an Option | $35,464 | |
| Exercise an Option | $46,616 | |
| Original award | $232,096 |
About this award
This is a federal contract award issued by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The $341,913.00 cost-plus-fixed-fee contract provides for the manufacture, qualification, and stability testing of TARP peptide and TWS-119 formulations to support the NCI's cancer research activities. This contract is issued under the NCI's $45 million "Drug Formulation and Manufacturing Contracts 2019" multiple-award indefinite delivery vehicle, which enables various NIH components to procure pharmaceutical development and manufacturing services. Societal CDMO San Diego, a contract development and manufacturing organization (CDMO), has provided similar services to other NIH institutes and the Department of Veterans Affairs for investigational new drug products and clinical trials.
Quick answers
Who was awarded contract 75N91019F00133?
75N91019F00133 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on September 27, 2019.
How much is contract 75N91019F00133 worth?
The government has obligated $341,913 on 75N91019F00133.
Is contract 75N91019F00133 an order under another contract?
Yes. 75N91019F00133 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract 75N91019F00133 competed?
The extent of competition for 75N91019F00133 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award